< Back to previous page
Researcher
Els Dequeker
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Biomedical Quality Assurance Research Unit (Division)
Responsible
From1 Jan 2012 → Today - Biomedical Quality Assurance Research Unit (Division)
Member
From1 Jan 2012 → Today - Department of Human Genetics (Department)
Member
From1 Oct 1999 → 31 Dec 2011
Projects
1 - 10 of 10
- The changing HER2 biomarker testing policy: Impact and training for the Belgian pathology laboratoriesFrom12 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Quality improvement of diagnostic processes in the oncology fieldFrom18 Oct 2021 → 15 Jan 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Evaluation of Scientific Publications to Predict the to be Expected Research Quality in Collaborations with External Service ProvidersFrom1 Oct 2021 → TodayFunding: Baekeland
- Quality improvement in molecular pathology laboratories: providing the means for process management and standardization of pre-analytical handling of small biopsies.From22 Apr 2021 → 8 Jan 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Organize distance laerning in the form of External Quality Assessment schemes.From1 Oct 2018 → 30 Sep 2019Funding: Private funding of national origin - undefined
- Early prediction/detection of clinical response in metastatic NSCLC by improving liquid biopsy analysisFrom4 Sep 2017 → 1 Jan 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Quality in Molecular Oncology Testing Laboratories in Europe: a View from Different AnglesFrom18 Jul 2016 → 22 Dec 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Quality improvement tools for predictive testing in pathologyFrom11 Sep 2015 → 28 Aug 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Future of Personalised Medicine: Quality Assurance of Oncology Biomarker Testing is EssentialFrom1 Aug 2013 → 21 Jan 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
- EuroGentest2: Genetic testing in Europe - Network for the further development, harmonization, validation and standardization of services.From1 Jan 2011 → 31 Dec 2013Funding: General Activities (Annex IV)
Publications
1 - 10 of 94
- Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic: role of the Belgian National Reference Centre(2024)
Authors: Kristel Van Laethem, Annabel Rector, Piet Maes, Marc Van Ranst, Katrien Lagrou, Els Dequeker, Emmanuel Andre
- Exploring the knowledge of genetics laboratories on CFTR modulator therapy eligibility: findings and reflections during external quality assessment(2024)
Authors: Nele Laudus, Els Dequeker
Pages: 635 - 636 - Evolution of circulating tumour DNA analysis in France over 5 years(2023)
Authors: Els Dequeker
Pages: S1194 - S1194 - The Upgrade Risk of B3 Lesions to (Pre)Invasive Breast Cancer After Diagnosis on Core Needle or Vacuum Assisted Biopsy. A Belgian National Cohort Study(2023)
Authors: Patrick Neven, Beppe Floris, Eva Oldenburger, Sileny Han, Chantal Van Ongeval, Ann Smeets, Hans Wildiers, Nele Laudus, Els Dequeker
Pages: E273 - E280 - Quality in Molecular Oncology Testing Laboratories in Europe: a View from Different Angles(2022)
Authors: Kelly Dufraing, Els Dequeker
- Expert opinion on NSCLC small specimen biomarker testing - Part 2: Analysis, reporting, and quality assessment(2022)
Authors: Els Dequeker
Pages: 351 - 366 - Expert opinion on NSCLC small specimen biomarker testing - Part 1: Tissue collection and management(2022)
Authors: Els Dequeker
Pages: 335 - 350 - Recommendations for reporting results of diagnostic genomic testing(2022)
Authors: Els Dequeker
Pages: 1011 - 1016 - The Significance of External Quality Assessment Schemes for Molecular Testing in Clinical Laboratories(2022)
Authors: Nele Laudus, Els Dequeker
Pages: 3686 - 3686 - External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices(2022)
Authors: Nele Laudus, Beppe Floris, Els Dequeker